Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents
- 1 May 1993
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (5) , 1150-1153
- https://doi.org/10.1128/aac.37.5.1150
Abstract
The in vitro activities of sparfloxacin, temafloxacin, ciprofloxacin, ofloxacin, clarithromycin, erythromycin, tetracycline, cephalothin, penicillin G, and amoxicillin-clavulanic acid against 173 recent clinical bite wound isolates were determined by agar dilution. Sparfloxacin was active against all strains (MIC for 90% of strains tested, < or = 1 micrograms/ml) except for most fusobacteria and one-third of the Prevotella spp. The other fluoroquinolones had similar activities but higher MICs, especially for streptococci. Clarithromycin was more active against many isolates including Pasteurella multocida than erythromycin, with MICs of < or = 2 micrograms/ml (versus 4 micrograms/ml for erythromycin).Keywords
This publication has 13 references indexed in Scilit:
- Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1992
- In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacinAntimicrobial Agents and Chemotherapy, 1991
- In vitro activity of sparfloxacinAntimicrobial Agents and Chemotherapy, 1991
- Trimethoprim/Sulfamethoxazole Therapy of Pasteurella multocida InfectionThe Journal of Infectious Diseases, 1989
- Comparative in vitro activities of new 14-, 15-, and 16-membered macrolidesAntimicrobial Agents and Chemotherapy, 1988
- Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite woundsAntimicrobial Agents and Chemotherapy, 1988
- Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocidaAntimicrobial Agents and Chemotherapy, 1988
- Microbiology of human and animal bite wounds in childrenThe Pediatric Infectious Disease Journal, 1987
- Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapyAntimicrobial Agents and Chemotherapy, 1986
- Antibiotic susceptibilities of human isolates of Pasteurella multocidaAntimicrobial Agents and Chemotherapy, 1979